Aetna and Merck Sign a Unique Value-Based Contract for Januvia® and Janumet®
October 11 2016 - 8:45AM
Business Wire
-- Merck also agrees to collaborate on
AetnaCareSM – Aetna’s personalized, patient-centric approach to
care --
Aetna (NYSE: AET) announced today that it has entered into a
value-based agreement with Merck (NYSE: MRK) for the type 2
diabetes medications Januvia® (sitagliptin) and Janumet®
(sitagliptin plus metformin).
Merck will also become the first health care company to
participate in AetnaCareSM, a new personalized health and wellness
care initiative that provides members the knowledge, tools, and
support to take a proactive role in managing their own health.
Measuring value differently
Merck and Aetna have entered into a unique value-based contract
that supports the objectives of Aetna and Merck to help adult
patients with type 2 diabetes access appropriate treatment. Under
this agreement, Merck’s rebates on Januvia and Janumet will be
based in part on those products’ contributions to helping Aetna’s
commercial member population with type 2 diabetes achieve or
maintain treatment objectives.
“At Aetna, we believe that focusing on how physicians prescribe
medications in real world settings is a key element in determining
the value of the treatment,” said Dr. Harold L. Paz, Executive Vice
President and Chief Medical Officer for Aetna. “It is in everyone’s
interest to ensure that patients receive appropriate medicines to
help patients achieve their treatment goals.”
“Merck shares Aetna’s commitment to focusing on patients, and we
are confident that the value-based agreement will help advance our
common goal of helping patients with type 2 diabetes,” said Robert
McMahon, President, U.S. Market, Global Human Health, Merck.
What is AetnaCare?
In a separate initiative, Merck is also collaborating with Aetna
on AetnaCare, a new innovative health approach which uses
predictive analytics to identify target populations and proactively
curate various health and wellness services that are available to
each member. Working with a patient’s physicians and other
caregivers, the program is designed to support treatment adherence,
ensure that critical social support needs are met, and reinforce
healthy lifestyle behaviors. The AetnaCare program will initially
target patients with diabetes and hypertension in Mid-Atlantic
markets.
“Today, individuals receive care in a variety of ways, including
retail clinics, healthcare devices, pharmaceutical services,
behavioral health, and social services, yet these services remain
uncoordinated,” said Dr. Paz. “Working with their physicians,
AetnaCare not only integrates all these services into a coherent
plan for members, it also curates care so patients don’t have to
figure out for themselves how to get the treatment they need.”
How is AetnaCare different?
AetnaCare is unique in being the first in the industry to
combine three key features:
- Real-time identification of the target
population using advanced analytics
- Individually customized care maps that
promote evidence-based actions for specific conditions
- Health ecosystem curation that brings
together appropriate clinical and non-clinical services
The foundation of AetnaCare is an analytically driven care map –
a longitudinal, customized and targeted health and wellness plan
for individuals with a particular chronic medical condition. These
care maps are triggered by key vulnerable moments in a member’s
health journey, during which AetnaCare nurses meet with members –
often in person and at home – to educate them about their
condition, explain the value of key health services (such as
nutrition, behavioral health, etc.), and working with their
physician to develop an actionable health and wellness plan to help
members achieve their personal health goals.
How is Merck collaborating with Aetna on AetnaCare?
The key to AetnaCare is building a health ecosystem in which
every facet of the healthcare system is working to improve outcomes
for patients. Merck has used its insights and experience to develop
educational resources and tools to help address patient engagement,
patient behavior and treatment adherence. Aetna will incorporate
some of these resources from Merck’s inventory into AetnaCare to
support more effective patient self-management. “Merck is pleased
to collaborate with Aetna on this unique patient-centered approach
to care by sharing our adherence and educational resources to help
support the health and wellness of AetnaCare members,” said Mr.
McMahon.
About AetnaAetna is one of the nation's leading
diversified health care benefits companies, serving an estimated
46.3 million people with information and resources to help them
make better informed decisions about their health care. Aetna
offers a broad range of traditional, voluntary and
consumer-directed health insurance products and related services,
including medical, pharmacy, dental, behavioral health, group life
and disability plans, and medical management capabilities, Medicaid
health care management services, workers' compensation
administrative services and health information technology products
and services. Aetna's customers include employer groups,
individuals, college students, part-time and hourly workers, health
plans, health care providers, governmental units,
government-sponsored plans, labor groups and expatriates. For more
information, see www.aetna.com and learn about how Aetna is helping
to build a healthier world. @AetnaNews
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161011005573/en/
Media Contact:AetnaCaryn Marshall, 646-561-0867Director
of Communications, Health & Wellnessmarshallc6@aetna.com
Aetna (NYSE:AET)
Historical Stock Chart
From Aug 2024 to Sep 2024
Aetna (NYSE:AET)
Historical Stock Chart
From Sep 2023 to Sep 2024